article thumbnail

Competitor Analysis Framework: How-To and Best Practices

Alpha Sense BI

A competitor analysis framework is a strategic tool that empowers corporations to systematically study and understand their competitors’ strengths, weaknesses, strategies, and market positioning—and then benchmark it against their own to create an effective strategy.

article thumbnail

Know where your competitors are conducting clinical trials!

Sedulo

Assess and benchmark enrollment timing. As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations.

Biotech 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ep. 552 – HMRP Monday Edition: John Dick, Founder & CEO of Civic Science; Managing Gen Z in the Modern Workplace

Happy Market

So – but that – we’re not giving up on that at all, we needed that survey frankly to benchmark that for us and realize, we actually have a lot of work to do to instill some of those really core principles that we had when we were all working in the same building together to today.

article thumbnail

Q3 Earnings Season: Key Takeaways From Top 26 Companies

Alpha Sense BI

When benchmarked against peers in the industry, Raytheon’s margin movement was quite volatile this quarter. M&A IPOs to watch in Pharma and Biotech. The lowered guidance reflects softer results for Intelligence & Space and Missiles & Defense. The CFO provides insights into why that was the case: . JOYY Inc. [YY].

Sales 52
article thumbnail

2025 Healthcare Outlook: Uncertainty and Innovation

Alpha Sense BI

RFK), have clouded 2025 visibility for the healthcare sector and generated a mix of expectations for healthcare systems and providers, health insurers, and biotech/pharma companies. Director with a large managed care organization Biotech and Pharma The Trump administration is expected to bring a relaxation of antitrust enforcement.